clinical trial · NCT06940102
Real-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive Tumors
Changchun GeneScience Pharmaceutical Co., Ltd.·—·recruiting·n = 120
CachexiaDigestive System CancerGastric CancerColorectal CancerHepatocellular CarcinomaNano-crystalline Megestrol Acetate Oral SuspensionTKI-Based Therapy
brief summary
This study is a prospective, observational clinical study aimed at evaluating the efficacy of Megestrol Acetate for cachexia in patients with advanced digestive system tumors receiving TKI-based therapy.
started
Mar 12, 2025
primary completion
Mar 1, 2026
completion
Dec 1, 2026
last updated
Apr 23, 2025
official title
A Multicenter, Real-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in Patients With Advanced Digestive System Tumors Receiving TKI-Based Therapy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol